Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001311676 | SCV000521561 | likely benign | not provided | 2021-04-14 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 20574985, 18337137, 28841266) |
Labcorp Genetics |
RCV000540060 | SCV000632578 | likely benign | Renal carnitine transport defect | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000540060 | SCV001317232 | uncertain significance | Renal carnitine transport defect | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ce |
RCV001311676 | SCV001501952 | uncertain significance | not provided | 2020-07-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000540060 | SCV002055761 | likely benign | Renal carnitine transport defect | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Giacomini Lab, |
RCV000540060 | SCV002576599 | likely benign | Renal carnitine transport defect | 2022-10-03 | criteria provided, single submitter | research | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003235209 | SCV003934856 | uncertain significance | not specified | 2023-05-09 | criteria provided, single submitter | clinical testing | Variant summary: SLC22A5 c.934A>G (p.Ile312Val) results in a conservative amino acid change located in the major facilitator superfamily domain (IPR020846) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00085 in 251494 control chromosomes, predominantly at a frequency of 0.0017 within the Non-Finnish European subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in SLC22A5 causing Systemic Primary Carnitine Deficiency (0.00085 vs 0.0046), allowing no conclusion about variant significance. c.934A>G has been reported in the literature as a VUS in the heterozygous state in individuals with cardiomyopathy suspected of Systemic Primary Carnitine Deficiency and as an uninformative genotype (i.e. zygosity not specified) in a case of sudden unexplained death (e.g. Amat di San Filippo_2008, Li_2010, Christiansen_2016). These reports do not provide unequivocal conclusions about association of the variant with Systemic Primary Carnitine Deficiency. Publications reporting experimental evidence evaluating an impact on protein function found that the variant has little impact on carnitine transport, maintaining above 65% of WT activity (e.g. Amat di San Filippo_2008, Frigeni_2017). The following publications have been ascertained in the context of this evaluation (PMID: 18337137, 27650965, 28841266, 20574985). Six submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as either likely benign (n=4) or VUS (n=2). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. |
Genome Diagnostics Laboratory, |
RCV001311676 | SCV001929686 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001311676 | SCV001976323 | likely benign | not provided | no assertion criteria provided | clinical testing |